On August 10, 2020, Xtant Medical Holdings, Inc. (NYSE American: XTNT) ("the Company"), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has entered into a Restructuring and Exchange Agreement with the lenders under its credit facility to restructure Xtant’s outstanding indebtedness, including the exchange of certain indebtedness outstanding under the facility, together with accrued and unpaid interest thereon, into shares of Xtant common stock.
The primary purpose of the restructuring is to improve Xtant’s capital structure by reducing its outstanding debt, which the Company expects will facilitate future access to capital markets for investment in its growth initiatives, and provide a path to possibly regain compliance with the NYSE American continued listing standards.
Duff & Phelps served as a financial advisor to the special committee of the board of directors of Xtant Medical Holdings, Inc.and provided a fairness opinion in connection with the transaction.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Fox Rothschild LLP served as legal counsel to Xtant Medical Holdings, Inc. and Stoel Rives LLP served as legal counsel to the special committee.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Comprehensive Due Diligence Solution
Comprehensive diligence support primarily in the areas of tax, compliance and regulatory, operations, financial and accounting, investigations and disputes and cyber/IT risk.
Middle-market M&A advisory differentiated by industry expertise and superior deal execution.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Private Capital Markets
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.
has agreed to acquire
Leading provider of charging solutions for electric vehicles
has sold the assets of
a portfolio company of
has been acquired by
has entered into an agreement to sell its Life Sciences division to
Duff & Phelps Advised Cristian Lay on its acquisition of Grupo Gallardo to KKR on the standstill agreement between all lenders, assist with cash management, financial due diligence and operational due diligence.
Healthcare Services Sector Update – December 2020
Global Telco Infrastructure Update – Q4 2020
Healthcare Services Sector Update – November 2020
Duff & Phelps Recommended U.S. Equity Risk Premium Decreased from 6.0% to 5.5%, Effective December 9, 2020
Duff & Phelps Announces CEO Transition
Duff & Phelps Strengthens German M&A Advisory Practice With the Appointment of Frank Bretag
Duff & Phelps Strengthens Transaction Advisory Services Practice with Appointment of New Managing Director
Professional Golfers’ Future Career Value Driven by Younger, More Global Field, Duff & Phelps Study Finds